FDA Approves Lower-Dose Moderna COVID-19 Vaccine
The US Food and Drug Administration (FDA) has approved a new, lower-dose COVID-19 vaccine from Moderna. This vaccine, mNexspike, will be available to adults 65 and older, as well as those aged 12 to 64 with at least one health condition that puts them at increased risk of severe disease. The approval marks a shift … Read more